Clinical Trials Browser

Phase 2/3 × INDUSTRY × pegylated granulocyte colony-stimulating factor × Clear all

NCT04554056 2022-12-02

Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

Phase 2/3 Completed

Breast Cancer Female